FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis
Europe - FRA:FRE - DE0005785604 - Common Stock
47.37 EUR
+0.25 (+0.53%)
FRE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 28 industry peers in the Health Care Providers & Services industry. FRE has only an average score on both its financial health and profitability. FRE is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year FRE was profitable.
In the past year FRE had a positive cash flow from operations.
FRE had positive earnings in 4 of the past 5 years.
FRE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 2.72%, FRE is doing good in the industry, outperforming 64.29% of the companies in the same industry.
With a Return On Equity value of 6.15%, FRE perfoms like the industry average, outperforming 53.57% of the companies in the same industry.
With a Return On Invested Capital value of 3.29%, FRE perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for FRE is below the industry average of 5.66%.
The 3 year average ROIC (1.83%) for FRE is below the current ROIC(3.29%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.72% | ||
| ROE | 6.15% | ||
| ROIC | 3.29% |
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
1.3 Margins
FRE has a better Profit Margin (5.06%) than 85.71% of its industry peers.
In the last couple of years the Profit Margin of FRE has declined.
FRE's Operating Margin of 9.96% is amongst the best of the industry. FRE outperforms 82.14% of its industry peers.
FRE's Operating Margin has declined in the last couple of years.
FRE has a Gross Margin (25.40%) which is in line with its industry peers.
FRE's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.96% | ||
| PM (TTM) | 5.06% | ||
| GM | 25.4% |
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FRE is destroying value.
Compared to 1 year ago, FRE has about the same amount of shares outstanding.
FRE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, FRE has an improved debt to assets ratio.
2.2 Solvency
FRE has an Altman-Z score of 2.10. This is not the best score and indicates that FRE is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.10, FRE is doing good in the industry, outperforming 64.29% of the companies in the same industry.
The Debt to FCF ratio of FRE is 10.07, which is on the high side as it means it would take FRE, 10.07 years of fcf income to pay off all of its debts.
FRE has a Debt to FCF ratio (10.07) which is in line with its industry peers.
FRE has a Debt/Equity ratio of 0.61. This is a neutral value indicating FRE is somewhat dependend on debt financing.
FRE has a Debt to Equity ratio of 0.61. This is in the better half of the industry: FRE outperforms 78.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 10.07 | ||
| Altman-Z | 2.1 |
ROIC/WACC0.63
WACC5.2%
2.3 Liquidity
A Current Ratio of 1.31 indicates that FRE should not have too much problems paying its short term obligations.
The Current ratio of FRE (1.31) is better than 67.86% of its industry peers.
A Quick Ratio of 1.00 indicates that FRE may have some problems paying its short term obligations.
FRE has a Quick ratio of 1.00. This is in the better half of the industry: FRE outperforms 60.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.31 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 1090.91% over the past year.
The Earnings Per Share has been decreasing by -2.29% on average over the past years.
FRE shows a small growth in Revenue. In the last year, the Revenue has grown by 0.89%.
The Revenue has been decreasing by -9.22% on average over the past years.
EPS 1Y (TTM)1090.91%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%6.17%
Revenue 1Y (TTM)0.89%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%
3.2 Future
FRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.84% yearly.
Based on estimates for the next years, FRE will show a small growth in Revenue. The Revenue will grow by 4.86% on average per year.
EPS Next Y10.11%
EPS Next 2Y10.73%
EPS Next 3Y10.03%
EPS Next 5Y9.84%
Revenue Next Year4.76%
Revenue Next 2Y4.84%
Revenue Next 3Y4.83%
Revenue Next 5Y4.86%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
FRE is valuated correctly with a Price/Earnings ratio of 14.49.
Based on the Price/Earnings ratio, FRE is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
FRE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.20.
Based on the Price/Forward Earnings ratio of 12.84, the valuation of FRE can be described as correct.
Based on the Price/Forward Earnings ratio, FRE is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, FRE is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.49 | ||
| Fwd PE | 12.84 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as FRE.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of FRE indicates a slightly more expensive valuation: FRE is more expensive than 67.86% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.93 | ||
| EV/EBITDA | 10.36 |
4.3 Compensation for Growth
FRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.43
PEG (5Y)N/A
EPS Next 2Y10.73%
EPS Next 3Y10.03%
5. Dividend
5.1 Amount
FRE has a Yearly Dividend Yield of 2.12%. Purely for dividend investing, there may be better candidates out there.
FRE's Dividend Yield is a higher than the industry average which is at 2.57.
Compared to an average S&P500 Dividend Yield of 2.38, FRE has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.12% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
58.31% of the earnings are spent on dividend by FRE. This is a bit on the high side, but may be sustainable.
DP58.31%
EPS Next 2Y10.73%
EPS Next 3Y10.03%
FRA:FRE (9/17/2025, 3:31:07 PM)
47.37
+0.25 (+0.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners36.44%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.68B
Analysts85.22
Price Target50.9 (7.45%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.12% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP58.31%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.26%
Min EPS beat(2)8.91%
Max EPS beat(2)17.61%
EPS beat(4)3
Avg EPS beat(4)8.92%
Min EPS beat(4)-3.48%
Max EPS beat(4)17.61%
EPS beat(8)4
Avg EPS beat(8)-53.85%
EPS beat(12)6
Avg EPS beat(12)-41.15%
EPS beat(16)8
Avg EPS beat(16)-31.82%
Revenue beat(2)2
Avg Revenue beat(2)2.07%
Min Revenue beat(2)1.31%
Max Revenue beat(2)2.84%
Revenue beat(4)4
Avg Revenue beat(4)1.74%
Min Revenue beat(4)0.41%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)0.19%
Revenue beat(12)5
Avg Revenue beat(12)-0.11%
Revenue beat(16)6
Avg Revenue beat(16)0%
PT rev (1m)2.97%
PT rev (3m)4.11%
EPS NQ rev (1m)0.44%
EPS NQ rev (3m)7.67%
EPS NY rev (1m)0.01%
EPS NY rev (3m)0.01%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)1.7%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-0.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.49 | ||
| Fwd PE | 12.84 | ||
| P/S | 1.2 | ||
| P/FCF | 20.93 | ||
| P/OCF | 11.86 | ||
| P/B | 1.46 | ||
| P/tB | 18.35 | ||
| EV/EBITDA | 10.36 |
EPS(TTM)3.27
EY6.9%
EPS(NY)3.69
Fwd EY7.79%
FCF(TTM)2.26
FCFY4.78%
OCF(TTM)3.99
OCFY8.43%
SpS39.46
BVpS32.46
TBVpS2.58
PEG (NY)1.43
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.72% | ||
| ROE | 6.15% | ||
| ROCE | 6.7% | ||
| ROIC | 3.29% | ||
| ROICexc | 3.6% | ||
| ROICexgc | 7.96% | ||
| OM | 9.96% | ||
| PM (TTM) | 5.06% | ||
| GM | 25.4% | ||
| FCFM | 5.74% |
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
ROICexc(3y)1.84%
ROICexc(5y)2.65%
ROICexgc(3y)3.69%
ROICexgc(5y)5.83%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexcg growth 3Y-17.75%
ROICexcg growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score8
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 10.07 | ||
| Debt/EBITDA | 3.32 | ||
| Cap/Depr | 86.89% | ||
| Cap/Sales | 4.38% | ||
| Interest Coverage | 6.1 | ||
| Cash Conversion | 67.46% | ||
| Profit Quality | 113.33% | ||
| Current Ratio | 1.31 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.1 |
F-Score8
WACC5.2%
ROIC/WACC0.63
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1090.91%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%6.17%
EPS Next Y10.11%
EPS Next 2Y10.73%
EPS Next 3Y10.03%
EPS Next 5Y9.84%
Revenue 1Y (TTM)0.89%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%
Revenue Next Year4.76%
Revenue Next 2Y4.84%
Revenue Next 3Y4.83%
Revenue Next 5Y4.86%
EBIT growth 1Y69.58%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year65.74%
EBIT Next 3Y23.83%
EBIT Next 5Y15.64%
FCF growth 1Y-50.31%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-49.36%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%